MARINUS PHARMACEUTICALS INC's ticker is and the CUSIP is 56854Q200. A total of 85 filers reported holding MARINUS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,117,879 | -35.0% | 138,867 | -12.3% | 0.00% | -100.0% |
| Q2 2023 | $1,719,551 | -18.0% | 158,338 | -47.9% | 0.00% | 0.0% |
| Q1 2023 | $2,095,792 | +4403.0% | 303,738 | +2497.4% | 0.00% | – |
| Q4 2022 | $46,542 | -31.6% | 11,694 | -16.9% | 0.00% | – |
| Q2 2022 | $68,000 | -71.7% | 14,078 | -45.1% | 0.00% | – |
| Q1 2022 | $240,000 | -82.4% | 25,662 | -66.3% | 0.00% | – |
| Q2 2021 | $1,366,000 | +0.9% | 76,102 | -13.0% | 0.00% | – |
| Q1 2021 | $1,354,000 | +284.7% | 87,455 | +202.7% | 0.00% | – |
| Q4 2020 | $352,000 | -65.0% | 28,893 | -63.1% | 0.00% | – |
| Q3 2020 | $1,007,000 | – | 78,361 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 2,145,337 | $17,269,963 | 7.70% |
| Bleichroeder LP | 1,872,463 | $15,073,327 | 3.72% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,204,942 | $41,899,783 | 2.26% |
| Opaleye Management Inc. | 584,000 | $4,701,200 | 1.53% |
| Bain Capital Life Sciences Investors, LLC | 1,431,058 | $11,520,017 | 1.29% |
| Cormorant Asset Management, LP | 2,625,000 | $21,131,250 | 1.23% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 290,000 | $2,337,400 | 0.79% |
| Ikarian Capital, LLC | 746,069 | $6,005,856 | 0.72% |
| Eventide Asset Management | 4,529,997 | $36,466,476 | 0.66% |
| Altium Capital Management LP | 125,033 | $1,006,516 | 0.52% |